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Sodium transport through various nephron segments is quite important in regulating sodium reabsorption and blood pressure.
Among several regulators of this process, insulin acts on almost all the nephron segments and is a strong enhancer of sodium
reabsorption. Sodium-proton exchanger type 3 (NHE3) is a main regulator of sodium reabsorption in the luminal side of
proximal tubule. In the basolateral side of the proximal tubule, sodium-bicarbonate cotransporter (NBCe1) mediates sodium
and bicarbonate exit from tubular cells. In the distal nephron and the connecting tubule, epithelial sodium channel (ENaC) is of
great importance to sodium reabsorption. NHE3, NBCe1, and ENaC are all regulated by insulin. Recently with-no-lysine (WNK)
kinases, responsible for familial hypertension, stimulating sodium reabsorption in the distal nephron, have been found to be
also regulated by insulin. We will discuss the regulation of renal sodium transport by insulin and its roles in the pathogenesis of
hypertension in insulin resistance.
1.Introduction
Obesity is frequently accompanied with hypertension [1].
Obesity is, at the same time, closely related to hyperinsuline-
mia and insulin resistance [2]. While the precise mechanism
of hypertension in insulin resistance remains to be clariﬁed,
the activation of sympathetic nerve system, the disorders
dysregulation of central nerve system including leptin, and
the activation of renin-angiotensin system are generally
thought to be involved [1]. Although insulin has powerful
stimulatory eﬀects on renal sodium transport, it remains
controversial whether hyperinsulinemia itself is a cause of
hypertension.
Acute studies suggest that hyperinsulinemia may cause
sodium retention and increased sympathetic activity, which
will be an important cause of hypertension [3]. On the other
hand,hyperinsulinemiaduetoinsulinomaorchronicinsulin
infusion into animals do not signiﬁcantly elevate blood
pressure [4, 5]. Moreover, insulin itself has vasodilatory
actions [6], which is dependent on nitric oxide [7]. Thus, the
relationship between hyperinsulinemia and hypertension is
not obvious.
However, the inﬂuence of insulin on blood pressure may
be altered in insulin resistance. For example, the insulin-
induced vasodilation is impaired due to defects in PI3-
kinase signaling in insulin resistance [8, 9]. Moreover, several
recent data suggest that the insulin-induced enhancement of
renal sodium reabsorption is preserved or even enhanced
in insulin resistance [10–12]. For example, Rocchini et
al. showed that, in obese subjects with insulin resistance,
urinary sodium excretion was decreased by insulin similarly
as in nonobese subjects [11]. These considerations support a
signiﬁcant role of insulin-stimulated renal sodium transport
in the pathogenesis of hypertension in insulin resistance.
This review will focus mainly on the regulation of sodium
reabsorption along the nephron segments by insulin and its
roles in the blood pressure control. Figure 1 shows the main
sodium transporters and regulators discussed in this review.
2. InsulinActing Sites upon Nephron
It has been known for a long time, that insulin acts upon the
whole nephron. Bourdeau et al. showed, using radioisotope
technique that insulin is accumulated in the proximal tubule2 International Journal of Hypertension
[13]. Nakamura et al. showed that insulin binds upon
various segments of rabbit nephron, among which it binds
strongest upon thick ascending limb of Henle’s loop and
distal convoluted tubule [14]. In rat nephron, Butlen et al.
showed that insulin is accumulated strongest in the proximal
tubule, second in the pars recta and distal convoluted tubule
[15]. The way that insulin arrives at the nephron seems to be
by two ways: one is by glomerular clearance, and the other
is peritubular clearance [16]. The former is by glomerular
ﬁltration and subsequent reabsorption from tubular cells
by endocytosis, the latter is diﬀusion from peritubular
capillaries and subsequent binding to the receptor.
3. InsulinandRenal ProximalAbsorption
Insulinuptakeintherenalproximaltubulehasbeenreported
on animals such as rabbits [13], rats [17], and dogs [18].
Importantly, insulin has been known to enhance sodium
reabsorption in the proximal tubule [19]. Insulin stimulates
not only sodium but also volume absorption in the rabbit
proximal convoluted tubule. Regarding these stimulatory
eﬀects, insulin acts only from the basolateral side of the
tubule, not from the luminal side [20]. Proximal tubules
reabsorb about seventy percents of total Na ﬁltered from
glomeruli. Though important regulatory mechanisms exist
afterwards in the Henle’s loop, distal tubule and connecting
tubule, the stimulation of Na reabsorption from proximal
tubules may well contribute to the increase of total ﬂuid
volume in the individual, leading to hypertension.
Gesek and Schoolwerth proved that insulin directly
increases the Na+-H+ exchanger type 3 (NHE3) activity in
proximal tubules of rats [21]. This is important because
NHE3 plays a major role in apical sodium entry in proximal
tubules. Although the signaling pathway of insulin-mediated
NHE3 activation remains unclear, Akt is known to play
a critical role in the phosphoinositide 3-kinase- (PI3K-)
mediated translocation of NHE3 into the apical membranes
of proximal tubular cells [22–24]. The PI3K pathway has also
chronic and posttranscriptional eﬀects on the re-gulation of
NHE3 mRNA in the proximal tubule cell [20, 25, 26].
It has been shown that Na-K-ATPase is also a target
of insulin, contributing to the increase of Na reabsorption
[27, 28]. Feraille et al. have showed that, in rat proximal
convoluted tubule, insulin stimulates Na-K-ATPase activity
[29]. Insulin is also known to stimulate the basolateral
electrogenic Na-HCO3 cotransporter (NBCe1), which plays
a major role in sodium and bicarbonate exit from proximal
tubular cells [30]. Therefore, insulin stimulates all the trans-
porters involved in Na absorption from proximal tubules.
4. InsulinandOther Renal Tubules
4.1. Henle’s Loop. Kirchner reported that insulin enhances
chloride reabsorption in the Henle’s loop of volume-
expanded rats [31]. This showed a possibility that insulin
may stimulate NaCl reabsorption in Henle’s loop. Later, in
rabbit kidney, it was shown that insulin directly stimulates
NaCl reabsorption in Henle’s loop [32]. Moreover, it was
suggested that Na-K-2Cl cotransporter (NKCC2) and Na-K-
ATPase are also involved in this stimulation [33]. Tsimaratos
et al. have clariﬁed that C-peptide, the cleavage product of
proinsulin, stimulates Na-K-ATPase in rat thick ascending
limb, which is mediated via protein kinase C (PKC) α
pathway [34]. They also showed that C-peptide activates
PKCα, which then stimulates the phosphorylation of Na-K-
ATPase α-subunit.
As about twenty percents of Na reabsorption is accom-
plished at Henle’s loop, stimulation of Na reabsorption
here should have a substantial impact on whole-body Na
homeostasis.
4.2. Distal Tubule and Connecting Tubule. In late tubule,
including distal and connecting tubules, it is widely known
that insulin stimulates the activity of amiloride-sensitive
epithelial sodium channel (ENaC) [35]. A study using
kidney-derived cell line has shown that the activation
of ENaC by insulin results from an increase of ENaC
channel density at the membrane [36]. Moreover, insulin
is known to stimulate Na-K-ATPase in this segment [37,
38]. Consistent with these ﬁndings, DeFronzo et al. found
that hyperinsulinemia and hyperglycemia enhance sodium
reabsorption from distal tubule [19]. Some studies showed
that insulin stimulates sodium transport via a signaling cas-
cade involving PI3K, 3-phosphoinositide-dependent protein
kinase (PDK1), and serum/glucocorticoid-kinase 1 (Sgk1)
[39, 40]. In distal tubule, there are other transporters and
kinases that are aﬀected by insulin, such as with-no-lysine
(WNK) kinases and sodium-chloride cotransporter (NCC),
which we will discuss later.
Distal and connecting tubules regulate only about ten
percents of total Na reabsorption in the nephron, but this
process cannot be ignored as the ﬁnal regulation of Na
reabsorption.
5. IRS1/2, Hyperinsulinemia,Insulin
Resistance, and Hypertension
Insulin receptor substrate (IRS) 1 was originally found
through an attempt to ﬁnd out the signal transduction
system of insulin [41, 42]. IRS1−/− m i c e ,h o w e v e r ,s u r v i v e d
with only a mild insulin resistance, which led to the
identiﬁcation of IRS2 [43]. The structures of IRS1 and IRS2
arequitesimilartoeachother[44],butthesignalingpathway
is diﬀerent [45]. IRS1 and IRS2 knockout mice develop
mental retardation and insulin resistance [46, 47]. IRS-1
and IRS-2 diﬀer in the tissue expression, the mechanism of
insulin resistance, and the association of β-cell hyperplasia
[48]. Some IRSs have been found later but IRS1 and IRS2 are
the most important among the IRS family.
Our group compared the eﬀects of insulin on proximal
tubule absorption in wild-type, IRS1−/− and IRS2−/− mice
[49]. In wild-type mice, insulin signiﬁcantly stimulated
Na-coupled HCO3
− absorption from proximal tubule. In
IRS1−/− mice, the stimulation of HCO3
− absorption by
insulin was preserved, but it was signiﬁcantly attenuated in
IRS2−/− mice. Moreover, the Akt phosphorylation inducedInternational Journal of Hypertension 3
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Figure 1: The main sodium transporters and regulators in the proximal tubule and distal and connecting/collecting tubules. In the
proximal tubule, insulin and Ang II stimulate NHE3 at the luminal side, NBCe1, and Na-K-ATPase at the basolateral side. In the distal
and connecting/collecting tubules, insulin stimulates ENaC and NCC in the luminal side, Na-K-ATPase at the basolateral side. Insulin may
also indirectly stimulate NCC via WNK kinases.
by insulin stimulation, which mimicked the eﬀect of insulin
on proximal absorption, was preserved in IRS1−/− mice but
signiﬁcantly attenuated in IRS2−/− mice. Consistent with
a major role of IRS2 in the insulin-mediated transport
stimulation in proximal tubules, the tyrosine phosphory-
lation of IRS2 by insulin was more prominent than that
of IRS1. Importantly, signaling defects speciﬁc to IRS1 has
been often reported in insulin resistance [50–53]. Thus,
sodium retention through IRS1-independent way, facilitated
by hyperinsulinemia, could be an important factor in the
pathogenesis of hypertension in insulin resistance.
6 .T um o rN ec r o s isF ac t o r(T N F )α and
Renal Sodium Absorption
TNFα is a pleiotropic 157-amino acid peptide cytokine.
It is committed in various physiological reactions, such
as inﬂammation, proliferation, cell diﬀerentiation, and cell
death including cell apoptosis [54, 55]. TNFα binds to TNF
receptor(TNFR),whichhastwosubtypes,calledTNFR1and
TNFR2.
It has been proposed for a long that TNFα causes insulin
resistance [56, 57]. Uysal et al. reported that mice lacking
TNFα function do not develop obesity-induced insulin
resistance [58]. However, TNFα alone may be insuﬃcient to
induce insulin resistance [59].
Interestingly, there are controversial papers about the
eﬀect of TNFα on sodium reabsorption. In C2BBe1 cells,
derived from human intestinal epithelial cell line, TNFα
was reported to reduce NHE3 expression via transcriptional
regulation [60, 61]. TNFα seems to reduce Sp1/Sp3 complex
to bind to NHE3 promoter DNA via cAMP/PKA way. Rela-
tively high concentrations, though within the physiological
levels, of TNFα are also known to increase urine volume and4 International Journal of Hypertension
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Figure 2: Mechanism of hypertension in insulin resistance. In insulin resistance, insulin-induced vasodilation is impaired. However, insulin
induced sodium reabsorption through various nephron segments seems to be preserved or enhanced.
sodium excretion [62]. On the contrary, TNFα was reported
to enhance sodium absorption from distal tubule in diabetic
rats[63,64].ThestimulationofsodiumuptakebyTNFαwas
blocked by amiloride, an inhibitor of ENaC, and PD98059,
an inhibitor of ERK. It seems that TNFα acts on sodium
status in a biphasic way: toward sodium excretion at high
concentrations [65] and sodium retention at low concen-
trations. The eﬀect of TNFα on renal sodium reabsorption
in the nondiabetic condition, however, remains to be
clariﬁed.
7. AngiotensinIIand InsulinResistance
Angiotensin II (Ang II) is important for its potent ability
to raise blood pressure. In addition to the vascular eﬀects,
Ang II stimulates sodium absorption from the proximal
tubule, acting on several transporters carrying sodium [66].
Renin-angiotensin system (RAS) is activated in insulin-
resistant state [67, 68]. RAS activation, on the other hand,
has been related to impaired insulin signaling and systemic
insulin resistance in various tissues and organs [69]. RAS
and insulin resistance are, therefore, believed to be closely
related. Moreover, numerous clinical evidences with RAS
inhibitors, such as ACE inhibitors and ARBs, show that the
inhibition of RAS contributes to amelioration of insulin
resistance,preventionofhypertension,anddamageoftissues
and organs.
Interestingly,AngIIisknowntoregulateproximaltubule
transport in a biphasic way: stimulation by low (picomo-
lar to nanomolar) concentrations and inhibition by high
(nanomolar to micromolar) concentrations. Studies using
Ang II type 1A receptor (AT1A) KO mice revealed that these
eﬀectso fA n gIIar emed i at edb yA T1 A[70,71].Interestingly,
the ERK pathway mediates the stimulatory eﬀect but not
the inhibitory eﬀect of Ang II in proximal tubules [72]. It
is unknown whether the stimulatory eﬀect of Ang II on
proximal tubule transport is enhanced in insulin resistance.
On the other hand, hyperglycemic state was shown
to stimulate Ang II expression in the proximal tubule
derived cells [73]. This is mediated by p44/42 MAPK signal
transduction system. Taken together, Ang II might act to
enhance sodium reabsorption from proximal tubule in both
acute and chronic phases of insulin resistance.
8. Kidney and WNK, Hypertension,andInsulin
WNK kinase was originally found as a kind of serine-
threonine kinase with an atypical lysine placement [74].
Notably, mutations in WNK kinases cause Gordon’s syn-
drome (pseudohypoaldosteronism type II (PHAII) or famil-
ial hyperkalemic hypertension (FHH)) [75]. This ﬁnding has
led to investigating the regulation of WNK kinases and their
eﬀects on renal transporters, such as NCC (sodium chlo-
ride cotransporter) and NKCC (sodium-potassium-chloride
cotransporter), in the context of blood pressure homeostasis.
WNKs have ﬁve subtypes: WNK1, WNK2, WNK3, and
WNK4, and a transcriptional variant of WNK1, KS-WNK1
[76]. In the distal tubule cells, NCC reabsorbs sodium
and chloride at the apical membrane. WNK4 reduces NCC
amount at the plasma membrane at least in some conditions
[75, 77–80]. On the other hand, WNK4 is reported to
enhance the NCC activity through its phosphorylation [81].
WNK1 does not aﬀect NCC activity itself but suppresses
WNK4 activity [78, 79]. KS-WNK1, which does not have
kinase domain of WNK1, inhibits the WNK1 action on
WNK4 [82, 83]. WNK3 stimulates NCC activity in its active
form, but exerts a negative eﬀect in its inactive form [84, 85].
In contrast to these distinct eﬀects of individual WNKs on
NCC, Heise et al. recently showed that WNKs 1, 3, and 4
all stimulate ENaC through serum glucocorticoid-induced
kinase (SGK) 1, and that these stimulatory eﬀects of WNKs
are mediated by their N-terminal sequences without kinase
activity [86]. These results suggest that WNKs regulate NCC
and ENaC through diﬀerent mechanisms.International Journal of Hypertension 5
Table 1: Eﬀects of insulin on renal transporters, channels, or
regulators.
Transporter/channel Eﬀects of insulin
Proximal
NBCe1 Stimulation
NHE Stimulation
Na-K-ATPase Stimulation
Henle NKCC Stimulation
Na-K-ATPase Stimulation
Distal
ENaC Stimulation
NCC Stimulation
Na-K-ATPase Stimulation
WNK4 ?
WNK1 ?
CNT ENaC Stimulation
Recently, there are some reports suggesting that insulin
has inﬂuence on the activity of WNKs, which may have a
role in the pathogenesis of salt-sensitive hypertension. For
WNK1, Vitari et al. showed that WNK1 is a substrate of
protein kinase B/Akt, a serine-threonine kinase known to
be downstream of insulin signaling. This ﬁnding suggests
that insulin may aﬀect blood pressure by regulating WNK1
[87]. For WNK4, Sohara et al. have revealed that the
WNK4 mutation (R1185C) induces excess phosphorylation
of WNK4 S1190, which is a target phosphorylation site by
insulin. They have also clariﬁed that the phosphorylation
of WNK4 S1190-OSR1/SPAK-NCC cascade is increased in
the mice with hyperinsulinemia. These ﬁndings suggest that
insulin regulates Na reabsorption from the distal tubule
through WNKs and is involved in the pathogenesis of salt-
sensitive hypertension [88]. Ellison et al. showed that the
WNK4-NCCpathwayaswellastheabundanceofWNK4was
altered in the rat model of insulin resistance [89]. Huang and
Kuo reported that insulin reduced the renal cortical WNK4
expression [90]. This would indirectly enhance NCC and
ENaC [91]. Now, the interaction between WNK kinases and
insulin is intensively investigated, so it is expected that, in
the near future, the regulatory system of insulin and distal to
connecting tubules will be much more clariﬁed.
Table 1 is a summary of insulin action on the regulators
of sodium transport in the nephron segment. Insulin acts
mostly as an enhancer of sodium reabsorption. The eﬀects of
insulin on WNKs require further investigations. Figure 2 is
a scheme about how insulin triggers the signal transduction
downstream and leads to hypertension.
9. Conclusion
We have discussed the renal actions of insulin. Sodium
transport along nephron segments is a key for regulating
blood pressure and sodium metabolism, with great inﬂuence
on cardiovascular management. There are several regulators
along each segment of the nephron. Among them, insulin
and its signal transduction system have outstanding features
andimportantrolesfromtheviewofhypertensionassociated
with insulin resistance. Moreover, WNKs seem to be impor-
tant mediators of insulin actions on the distal nephron.
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